Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > Articles online first > The Journal of Cardiovascular Surgery 2021 Jun 09

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

The Journal of Cardiovascular Surgery 2021 Jun 09

DOI: 10.23736/S0021-9509.21.11911-1

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Venous malformations

Jovan N. MARKOVIC , Cynthia K. SHORTELL

Department of Surgery, Division of Vascular Surgery, Duke University School of Medicine, Durham, NC, USA


PDF


The often inexorable growth and expansion of congenital vascular malformations can result in substantial morbidity and, in some cases, premature death of these patients. Despite this, patients suffering from such lesions are often erroneously diagnosed and/or inadequately treated, due to a lack of expertise among primary care practitioners as well as specialists. Venous malformations are the most common type of congenital vascular malformations. Over the last two decades management of these lesions has significantly improved, predominantly due to the introduction and implementation of multidisciplinary team concept as well as improvement in diagnostic and treatment modalities. Relatively recently genetic studies are providing more insights into underlying pathophysiological mechanisms responsible for the development and
progression of venous malformations and pharmacotherapy is becoming extensively evaluated for safety and efficacy in the treatment of these often challenging vascular lesions.


KEY WORDS: Venous malformations; Endovascular therapies; Peripheral vein diseases

top of page